Atlas Private Wealth Advisors’s Pacira BioSciences PCRX Stock Holding History

Atlas Private Wealth Advisors’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-100	Closed	-$6K	–	543
2021 Q3	$6K	Hold	100	–	–	﹤0.01%	541
2021 Q2	$6K	Hold	100	–	–	﹤0.01%	554
2021 Q1	$7K	Hold	100	–	–	﹤0.01%	550
2020 Q4	$6K	Hold	100	–	–	﹤0.01%	496
2020 Q3	$6K	Hold	100	–	–	0.01%	458
2020 Q2	$5K	Buy	+100	New	+$4.18K	﹤0.01%	509

Other funds holding PCRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

SCM

Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Atlas Private Wealth Advisors's PCRX Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Pacira BioSciences (PCRX) in Q4 2021, closing a stake of 100 shares — an estimated $6K sold.

Atlas Private Wealth Advisors first reported a position in PCRX in Q2 2020 and held it in 6 quarters. The position peaked at $7K in Q1 2021. 276 funds tracked by Wall St. Rank hold PCRX as of Q4 2021.

Atlas Private Wealth Advisors reported no remaining Pacira BioSciences position as of Q4 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 100 Pacira BioSciences shares in Q4 2021, an estimated $6K.
Atlas Private Wealth Advisors first reported a position in Pacira BioSciences in Q2 2020 and held it in 6 quarters.
Atlas Private Wealth Advisors's Pacira BioSciences position peaked at $7K in Q1 2021.
276 funds tracked by Wall St. Rank held Pacira BioSciences as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.